The main purpose of this legislation is to authorize the United States to participate in the Davos Alzheimer's Collaborative (DAC), a global initiative aimed at addressing Alzheimer's disease and dementia. The objectives include enhancing research, prevention, and treatment of these conditions, particularly in low- and middle-income countries where the prevalence is rising. Key provisions of the legislation include the authorization for the U.S. to contribute funding and resources to the DAC.